Caris Life Sciences (CAI) EBIT (2024 - 2026)
Caris Life Sciences (CAI) posted quarterly EBIT of $5.3 million for Q1 2026, up 109.11% year-over-year from $2.5 million in Q1 2025, and down 94.03% quarter-over-quarter from $88.4 million in Q4 2025.
Caris Life Sciences (CAI) EBIT (2024 - 2026) Analysis & Trends
Caris Life Sciences' EBIT history runs 3 years deep, the most recent figure standing at $5.3 million for Q1 2026.
- In Q1 2026, EBIT rose 109.11% year-over-year to $5.3 million; the TTM figure through Mar 2026 stood at $108.3 million (up 148.62% YoY), while the FY2025 annual figure was $45.1 million, up 117.55% from the prior year.
- EBIT for Q1 2026 stood at $5.3 million, down from $88.4 million in the prior quarter.
- The five-year high for EBIT was $88.4 million in Q4 2025, with the low at -$67.0 million in Q2 2024.
- The 3-year median for EBIT is -$27.5 million (2024), against an average of -$14.3 million.
- Peak annual rise in EBIT reached 338.65% in 2025, while the deepest fall reached 73.16% in 2025.
- Caris Life Sciences' EBIT stood at -$37.0 million in 2024, then surged by 338.65% to $88.4 million in 2025, then plunged by 94.03% to $5.3 million in 2026.
- Business Quant data shows CAI's EBIT at $5.3 million in Q1 2026, $88.4 million in Q4 2025, and $32.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 493.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 325.05 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,158.03 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 133.12 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 231.44 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.55 Mn |
| 10 | Caris Life Sciences | 6.16 Bn | 5.37 Bn | 182.38 Mn | 26.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.93 Mn |
| Mar 31, 2026 | 5.28 Mn |
| Dec 31, 2025 | 88.41 Mn |
| Sep 30, 2025 | 32.64 Mn |
| Jun 30, 2025 | -17.99 Mn |
| Mar 31, 2025 | -57.95 Mn |
| Dec 31, 2024 | -37.05 Mn |
| Sep 30, 2024 | -60.84 Mn |
| Jun 30, 2024 | -67.01 Mn |